world cancer report - iarc
world cancer report - iarc
world cancer report - iarc
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Parent<br />
heterozygous<br />
for RB1<br />
Chromosome 13<br />
with deletion<br />
of RB1<br />
Redox changes<br />
Temperature?<br />
Normal<br />
chromosome 13<br />
RB1<br />
Proliferation<br />
Proliferating retinoblastoma cells<br />
X-rays<br />
γ-rays<br />
Hypoxia<br />
Child<br />
heterozygous<br />
for RB1<br />
Somatic mutation with high frequency<br />
in retinal cell with loss of<br />
normal chromosome<br />
UV<br />
Binding to p53-interacting proteins<br />
Normal<br />
Parent<br />
Nonmalignant<br />
cells<br />
Fig. 3.18 The retinoblastoma gene is a paradigm<br />
for tumour suppressor genes: if a child inherits a<br />
mutation or deletion of one copy (“allele”) of the<br />
retinoblastoma gene, the remaining normal copy<br />
tends to be lost at a high frequency in cells of the<br />
retina, resulting in loss of function and in the formation<br />
of tumours. The diagram shows loss of the<br />
whole normal chromosome but the normal allele<br />
can also be lost by mutation, deletion, gene conversion<br />
or mitotic recombination.<br />
Fig. 3.19 Many types of biological stress lead to a p53-mediated response.<br />
98 Mechanisms of tumour development<br />
Cytotoxic<br />
drugs<br />
Activation or accumulation of p53 protein<br />
Myc transactivates a number of other cellular<br />
genes and has a wide spectrum of<br />
molecular effects (a phenomenon that<br />
may explain why Myc is activated in many<br />
different types of <strong>cancer</strong> cells).<br />
Activation of Myc often proceeds through<br />
amplification of the region containing the<br />
gene on chromosome 8, but Myc is also<br />
commonly activated by chromosomal<br />
translocation in some forms of B-cell<br />
leukaemia (Leukaemia, p242).<br />
BCL2<br />
The BCL2 gene (activated in B cell lymphomas)<br />
exemplifies another kind of<br />
oncogene. Initially identified as a gene<br />
located within a chromosomal breakpoint<br />
in some forms of leukaemia, BCL2 was<br />
found to encode a protein capable of<br />
extending the life span of a cell by preventing<br />
the onset of programmed cell<br />
death, or apoptosis [10] (Apoptosis,<br />
p113). Biochemical studies have revealed<br />
that BCL2 encodes a regulator of the permeability<br />
of the mitochondrial membrane.<br />
Mitochondrial damage and cytoplasmic<br />
leakage of mitochondrial components<br />
is one of the important signals that<br />
lead a cell to apoptosis. By helping to<br />
keep the mitochondrial permeability<br />
pores closed, Bcl-2 protein prevents this<br />
leakage and thus allows the survival of<br />
cells that would otherwise have been<br />
eliminated by a physiological process.<br />
Cytokines<br />
Ribonucleotide<br />
depletion<br />
Microtubule<br />
depletion<br />
Growth factor<br />
depletion<br />
Induction of p53 target genes<br />
Senescence<br />
Tumour suppressor genes: history of a<br />
concept<br />
Whereas the study of retroviruses and<br />
gene transfection experiments were the<br />
keys to the discovery of oncogenes,<br />
tumour suppressor genes were identified<br />
through the study of large DNA viruses<br />
and the analysis of familial tumour syndromes.<br />
Retinoblastoma<br />
In 1971, Knudsen proposed the now popular<br />
“two hits” hypothesis to explain the<br />
inheritance of retinoblastoma, a rare<br />
childhood tumour type [11,12] (Genetic<br />
susceptibility, p71). He postulated that, in<br />
a familial setting, individuals may inherit<br />
only one normal copy of the gene (localized<br />
by linkage studies to chromosome<br />
13q14), the other being either lost, partially<br />
deleted or otherwise inactivated.<br />
Consequently, these individuals would just<br />
need one additional mutagenic step to<br />
switch off the remaining copy of the gene,<br />
thus totally losing the corresponding function<br />
(Fig. 3.18). The very same type of <strong>cancer</strong><br />
may also occur in a sporadic manner,<br />
but in this case it would require two consecutive<br />
“hits” (mutagenic events) to inactivate<br />
the two copies of the gene in the<br />
same cell. This theory paved the way for<br />
the modern concept of recessive tumour<br />
suppressor genes. In 1988, the gene<br />
responsible for familial retinoblastoma<br />
was identified [13]. The RB1 gene encodes<br />
a protein that binds and inactivates transcription<br />
factors that are essential for the<br />
progression of the cell cycle, thus fulfilling<br />
the functions of a molecular “brake” on<br />
cell division.<br />
Large DNA viruses<br />
In parallel with events previously outlined,<br />
it became evident that many DNA viruses<br />
associated with <strong>cancer</strong> encode complex<br />
viral proteins that are capable of sequestering<br />
and inactivating cellular proteins<br />
[14]. This is the case of a tumorigenic<br />
simian virus, SV40, of several adenoma<br />
and polyoma viruses and of oncogenic<br />
forms of human papillomaviruses. In the<br />
case of SV40, the virus encodes a large<br />
protein (called LT for Large Tumour antigen)<br />
which binds two cellular proteins, the